GlassScriptPhysician profile
Eyad Khoury
NPI 1134140536
$881.27
in general payments reported to CMS, 2019-2025
18 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $40.31 · 2021: $78.67 · 2022: $229 · 2023: $152 · 2024: $40.58 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $228.27 | 2022-2025 | |
| Abbvie INC. | $152.60 | 2019-2022 | |
| Agile Therapeutics, INC. | $56.18 | 2022 | |
| Myovant Sciences INC. | $54.44 | 2022 | |
| Coopersurgical, INC. | $53.72 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $40.90 | 2019 | |
| Evofem Biosciences, INC. | $39.51 | 2021 | |
| Allergan, INC. | $37.25 | 2019 | |
| Astellas Pharma US INC | $35.61 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $25.69 | 2025 | Slynd |
| Sumitomo Pharma America, INC. | $25.01 | 2025 | Myfembree |
| Daiichi Sankyo INC. | $24.69 | 2022 | |
| Hologic Sales and Service, LLC | $23.77 | 2019 | |
| Shield Therapeutics INC | $22.62 | 2025 | |
| Organon LLC | $18.62 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $17.66 | 2025 | |
| Avion Pharmaceuticals | $13.28 | 2021 | |
| Lupin INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eyad Khoury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.